| rasagiline / Generic mfg. |
| Ongoing | 4 | 12 | Europe | Azilect, Cipralex, Azilect, Cipralex, Azilect, Cipralex | Oy Lundbeck | terveet vapaaehtoiset | | | | |
2006-005140-89: A PHASE I, DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED (WITHIN EACH GROUP) STUDY TO EVALUATE THE INTERACTION BETWEEN ORALLY ADMINISTERED TYRAMINE HYDROCHLORIDE AND RASAGILINE MESILATE IN HEALTHY SUBJECTS |
|
|
| Ongoing | 4 | 160 | Europe | Rasagiline 1mg tablet, Rasagiline 2 mg tablet, TVP-1012, Selegiline HCl 5 PCH, Nardil, Selegiline HCl 5 PCH, Nardil | TEVA Pharmaceuticals Industries Ltd | This postmarketing Phase I study is performed in healthy volunteers. The IMP rasagiline 1mg is indicated for the treatment of Parkinson\'s Disease (PD). | | | | |
2007-007397-28: Evaluation de la tolérance et de l’acceptabilité de la Rasagiline dans le traitement de la maladie de Parkinson au stade précoce |
|
|
| Ongoing | 4 | 240 | Europe | Azilect, Sifrol, Azilect, Sifrol, Azilect, Sifrol | Qualissima | Maladie de Parkinson idiopathique au stade précoceMaladie de Parkinson, numéro de classification MedDRA 10061536 | | | | |
2009-013004-31: Early combined prolonged release ropinirole and rasagiline therapy in newly diagnosed patients with Parkinsons disease. A prospective, randomized, parallel groups, long-term follow-up study including delayed-start design of rasagiline |
|
|
| Ongoing | 3 | 150 | Europe | Tablet, Prolonged-release tablet | UNIVERSITA, DEGLI STUDI DI PARMA | Patients with Parkinson, s diesease | | | | |
ACTRN12614000355673: Investigating the effect of Rasagiline on freezing of gait in Parkinson’s disease using accelerometry and functional MRI. |
|
|
| Not yet recruiting | 2/3 | 40 | | | A/Prof Simon Lewis, Lundbeck Australia | Freezing of gait in Parkinson's disease | | | | |
NCT05611372: Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease |
|
|
| Not yet recruiting | 2/3 | 732 | NA | Rasagiline | Second Affiliated Hospital, School of Medicine, Zhejiang University, Beijing Tiantan Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Jiangsu Province Nanjing Brain Hospital, The First Affiliated Hospital of Anhui Medical University, Huashan Hospital, Second Affiliated Hospital of Soochow University, Guizhou Medical University, The First Affiliated Hospital of Guangzhou Medical University, West China Hospital, Sir Run Run Shaw Hospital, The Affiliated Hospital of Hangzhou Normal University, The First Affiliated Hospital of Dalian Medical University, Qilu Hospital of Shandong University, Fujian Medical University Union Hospital | REM Sleep Behavior Disorder, Parkinson Disease, Synucleinopathies | 12/25 | 12/26 | | |
| Completed | 2 | 96 | US | Rasagiline, Azilect, MAO-B inhibitor, Placebo, Magnetic Resonance Imaging, MRI, functional Magnetic Resonance Imaging, fMRI, Physical Function Performance Test | University of Florida, National Institute of Neurological Disorders and Stroke (NINDS) | Parkinson's Disease | 05/23 | 05/23 | | |
2008-002145-22: Klinische Untersuchung zur Verträglichkeit und Wirksamkeit nach Umstellung von Selegilin auf Rasagilin bei Patienten mit Morbus Parkinson und Schlafstörungen. Prospektive, offene, explorative Studie mit Umstellung von Selegilin auf Rasagilin. |
|
|
| Ongoing | 1/2 | 30 | Europe | Rasagilin, Rasagilin (Azilect®), Rasagilin (Azilect®) | NeuroCode AG | Parkinsonpatienten, die bezüglich ihrer motorischen Tagesaktivität optimal eingestellt sind, leiden trotzdem vermehrt unter Tagesmüdigkeit und Schlafstörungen (Chaudhuri, 2002). Es wird angenommen, dass eine Umstellung der Patienten von Selegilin auf Rasagilin zu einer deutlichen klinischen Verbesserung, insbesondere der Schlafproblematik führen wird. | | | | |
ChiCTR1800017978: A randomized, open label, single-dose, double-cycle, double-crossover, fasting and feedbioequivalence trial of Rasagiline Mesylate tablets in healthy subjects |
|
|
| Recruiting | 1 | 108 | | T-R ;R-T ;T-R ; R-T | Beijing Shijitan Hospital Capital Medical University; Level of the institution：, Changzhou Siyao Pharmaceuticals Co., Ltd | parkinsonism | | | | |
ChiCTR1800016949: Efficacy assessment and standard treatment of rasagiline in Chinese patients with early Parkinson's disease |
|
|
| Not yet recruiting | N/A | 260 | | rasagiline-rasagiline ;placebo-rasagiline | Beijing Hospital; Beijing Hospital, Ministry of Science and Technology, China | Parkinson's disease | | | | |
| Completed | N/A | 1235 | Europe | | Zambon SpA, Iqvia Pty Ltd | Parkinson's Disease | 12/23 | 12/23 | | |